PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer’s Disease
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24033005 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Tommaso Cassano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Foggia, Via L. Pinto 1, 71122 Foggia, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza University of Rome, Sapienza University Intramural.
Themen: Demenz
Abstract (Originalsprache)
In the present study, we used a mouse model of Alzheimer’s disease (AD) (3×Tg-AD mice) to longitudinally analyse the expression level of PDIA3, a protein disulfide isomerase and endoplasmic reticulum (ER) chaperone, in selected brain limbic areas strongly affected by AD-pathology (amygdala, entorhinal cortex, dorsal and ventral hippocampus). Our results suggest that, while in Non-Tg mice PDIA3 levels gradually reduce with aging in all brain regions analyzed, 3×Tg-AD mice showed an age-dependent increase in PDIA3 levels in the amygdala, entorhinal cortex, and ventral hippocampus. A significant reduction of PDIA3 was observed in 3×Tg-AD mice already at 6 months of age, as compared to age-matched Non-Tg mice. A comparative immunohistochemistry analysis performed on 3×Tg-AD mice at 6 (mild AD-like pathology) and 18 (severe AD-like pathology) months of age showed a direct correlation between the cellular level of Aβ and PDIA3 proteins in all the brain regions analysed, even if with different magnitudes. Additionally, an immunohistochemistry analysis showed the presence of PDIA3 in all post-mitotic neurons and astrocytes. Overall, altered PDIA3 levels appear to be age- and/or pathology-dependent, corroborating the ER chaperone’s involvement in AD pathology, and supporting the PDIA3 protein as a potential novel therapeutic target for the treatment of AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, University of Foggia, Via L. Pinto 1, 71122 Foggia, Italy.
- Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
- Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy.
ORCID-Profile: Tommaso Cassano, Giuliano Paglia, Antonino Davide Romano, Marzia Friuli, Fabio Altieri
Förderung
- Sapienza University of Rome
- Sapienza University Intramural
Zitieren
APA
Cassano, T., Giamogante, F., Calcagnini, S., Romano, A., Lavecchia, A. M., Inglese, F., Paglia, G., Bukke, V. N., Romano, A. D., Friuli, M., Altieri, F., & Gaetani, S. (2023). PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24033005
Vancouver
Cassano T, Giamogante F, Calcagnini S, Romano A, Lavecchia AM, Inglese F, et al. PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer’s Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24033005
BibTeX
@article{Cassano2023,
author = {Cassano, Tommaso and Giamogante, Flavia and Calcagnini, Silvio and Romano, Adele and Lavecchia, Angelo Michele and Inglese, Francesca and Paglia, Giuliano and Bukke, Vidyasagar Naik and Romano, Antonino Davide and Friuli, Marzia and Altieri, Fabio and Gaetani, Silvana},
title = {PDIA3 Expression Is Altered in the Limbic Brain Regions of Triple-Transgenic Mouse Model of Alzheimer’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24033005}
}
EUVIMED